These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23261601)

  • 41. Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers.
    Secchi M; Grampa V; Vangelista L
    Sci Rep; 2018 Jan; 8(1):1890. PubMed ID: 29382912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. O-GalNAcylation of RANTES Improves Its Properties as a Human Immunodeficiency Virus Type 1 Entry Inhibitor.
    Guan X; Chaffey PK; Chen H; Feng W; Wei X; Yang LM; Ruan Y; Wang X; Li Y; Barosh KB; Tran AH; Zhu J; Liang W; Zheng YT; Wang X; Tan Z
    Biochemistry; 2018 Jan; 57(1):136-148. PubMed ID: 29202246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants.
    Secchi M; Xu Q; Lusso P; Vangelista L
    Protein Expr Purif; 2009 Nov; 68(1):34-41. PubMed ID: 19573605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.
    Gaertner H; Cerini F; Escola JM; Kuenzi G; Melotti A; Offord R; Rossitto-Borlat I; Nedellec R; Salkowitz J; Gorochov G; Mosier D; Hartley O
    Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17706-11. PubMed ID: 19004761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel interfering bifunctional molecules against the CCR5 coreceptor are efficient inhibitors of HIV-1 infection.
    Luis Abad J; González MA; del Real G; Mira E; Mañes S; Serrano F; Bernad A
    Mol Ther; 2003 Sep; 8(3):475-84. PubMed ID: 12946321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice.
    Petit NY; Baillou C; Burlion A; Dorgham K; Levacher B; Amiel C; Schneider V; Lemoine FM; Gorochov G; Marodon G
    Gene Ther; 2016 Feb; 23(2):144-50. PubMed ID: 26488891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5.
    Secchi M; Vassena L; Morin S; Schols D; Vangelista L
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6215-23. PubMed ID: 25114130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris.
    Cerini F; Gaertner H; Madden K; Tolstorukov I; Brown S; Laukens B; Callewaert N; Harner JC; Oommen AM; Harms JT; Sump AR; Sealock RC; Peterson DJ; Johnson SK; Abramson SB; Meagher M; Offord R; Hartley O
    Protein Expr Purif; 2016 Mar; 119():1-10. PubMed ID: 26506568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of intermolecular transferred-NOE interactions in small and medium size protein complexes: RANTES complexed with a CCR5 N-terminal peptide.
    Abayev M; Srivastava G; Arshava B; Naider F; Anglister J
    FEBS J; 2017 Feb; 284(4):586-601. PubMed ID: 28052516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemokine analogues show suitable stability for development as microbicides.
    Cerini F; Landay A; Gichinga C; Lederman MM; Flyckt R; Starks D; Offord RE; Le Gal F; Hartley O
    J Acquir Immune Defic Syndr; 2008 Dec; 49(5):472-6. PubMed ID: 18989226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES.
    Rusconi S; Merrill DP; La Seta-Catamancio S; Citterio P; Offord RE; Hirsch MS
    AIDS; 1999 Jun; 13(9):1144-5. PubMed ID: 10397549
    [No Abstract]   [Full Text] [Related]  

  • 52. Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.
    Tamamis P; Floudas CA
    Sci Rep; 2014 Jun; 4():5447. PubMed ID: 24965094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent D-peptide inhibitors of HIV-1 entry.
    Welch BD; VanDemark AP; Heroux A; Hill CP; Kay MS
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):16828-33. PubMed ID: 17942675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of peptides mimicking chemokine receptor CCR5 and their inhibitory effects against HIV-1 infection.
    Konishi K; Ikeda K; Achiwa K; Hoshino H; Tanaka K
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):308-9. PubMed ID: 10705530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Core chemotype diversification in the HIV-1 entry inhibitor class using field-based bioisosteric replacement.
    Tuyishime M; Lawrence R; Cocklin S
    Bioorg Med Chem Lett; 2016 Jan; 26(1):228-34. PubMed ID: 26531151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Effect of N-Terminal Cyclization on the Function of the HIV Entry Inhibitor 5P12-RANTES.
    F Nguyen A; S Schill M; Jian M; J LiWang P
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxyproline-containing collagen peptide derived from the skin of the Alaska pollack inhibits HIV-1 infection.
    Jang IS; Park SJ
    Mol Med Rep; 2016 Dec; 14(6):5489-5494. PubMed ID: 27878297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological evaluation of peptide mimics derived from first extracellular loop of CCR5 toward HIV-1.
    Ikeda K; Ishii Y; Konishi K; Sato M; Tanaka K
    Chem Pharm Bull (Tokyo); 2004 Dec; 52(12):1479-82. PubMed ID: 15577250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis.
    Amerzhanova Y; Vangelista L
    Front Immunol; 2022; 13():826418. PubMed ID: 35126399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineering chemokines to develop optimized HIV inhibitors.
    Hartley O; Offord RE
    Curr Protein Pept Sci; 2005 Jun; 6(3):207-19. PubMed ID: 15974948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.